Changes in phagocytic function with glycaemic control in diabetic patients

62Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Phagocytic function was assessed by serial whole blood chemiluminescence in poorly controlled type 2 (non-insulin dependent) diabetic patients during efforts to improve glycaemic control and compared with a group of well controlled type 1 (insulin dependent) diabetic patients. Chemiluminescence (corrected to a standard polymorphonuclear count) remained below normal (0·15-0·30 photons/second/cell) for most of the type 2 patients until 12 weeks when the value was significantly increased in patients showing improved glycaemic control (mean (range) 0·25 (0·01-0·43) photons/second/cell) compared with those showing no improvement (0·12 (0·01-0·31) photons/ second/cell). There was a significant inverse correlation of Δ HbA1 with Δ chemiluminescence. Although mean chemiluminescence for the type 1 diabetic patients was within the normal range, there was a wide scatter of values (0·19 (0·04-0·43) photons/second/cell) and there was no significant difference compared with the final value of type 2 patients with improved control. Glycaemic control is therefore a major determinant of phagocytic function in diabetic patients, but other factors must contribute, particularly in type 1 (insulin dependent) patients.

Cite

CITATION STYLE

APA

MacRury, S. M., Gemmell, C. G., Paterson, K. R., & MacCuish, A. C. (1989). Changes in phagocytic function with glycaemic control in diabetic patients. Journal of Clinical Pathology, 42(11), 1143–1147. https://doi.org/10.1136/jcp.42.11.1143

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free